A comparative study of non-invasive methods for fibrosis assessment in chronic HCV infection

Roxana Sirli1, Ioan Sporea, Simona Bota

  • 1Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, Timişoara, Romania. roxanasirli@gmail.com

Hepatitis Monthly
|February 8, 2012
PubMed

Insights

Non-invasive tests for liver fibrosis in chronic hepatitis C virus (HCV) infection, including Transient Elastography (TE), show promise. TE demonstrated the best prediction for significant fibrosis and cirrhosis, though differences among methods were not always significant.

Area of Science:

  • Hepatology
  • Diagnostic Medicine
  • Viral Hepatitis Research

Background:

  • Chronic hepatitis C virus (HCV) infection can lead to liver fibrosis and cirrhosis.
  • Accurate assessment of liver fibrosis is crucial for patient management.
  • Non-invasive methods are increasingly explored as alternatives to liver biopsy.

Purpose of the Study:

  • To compare the diagnostic accuracy of several non-invasive fibrosis assessment methods in chronic HCV patients.
  • To evaluate platelet count, APRI, Forns, Lok, FIB-4 scores, and Transient Elastography (TE) against percutaneous liver biopsy (LB).

Main Methods:

  • A study involving 150 chronic HCV patients.
  • All patients underwent percutaneous liver biopsy (LB) and liver stiffness measurement (LSM) via TE in the same session.
  • Biological tests for calculating APRI, Forns, Lok, and FIB-4 scores were performed concurrently.

Main Results:

  • Transient Elastography (TE) showed the highest AUROC (0.773) for predicting significant fibrosis (Metavir F≥2), followed closely by APRI (0.763) and Forns (0.744).
  • For predicting cirrhosis, TE (AUROC 0.979) was significantly superior to platelet count and FIB-4.
  • All non-invasive tests demonstrated excellent negative predictive values (>97%) for excluding cirrhosis and significant correlations with fibrosis severity.

Conclusions:

  • Liver stiffness measurement (LSM) via TE appears more sensitive for predicting significant fibrosis than other non-invasive scores, though not statistically significant.
  • APRI and Forns scores demonstrated good performance in identifying significant fibrosis.
  • LSM via TE is the optimal non-invasive method for predicting cirrhosis in chronic HCV patients.
Abstract

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...